Chargement en cours...
Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a highly malignant human cancer that has increasing mortality rates worldwide. Because CD133(+) cells control tumor maintenance and progression, compounds that target CD133(+) cancer cells could be effective in combating HCC. We found that the administration of chro...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7281429/ https://ncbi.nlm.nih.gov/pubmed/32397206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051193 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|